TerminatedNCT00169039
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia
Medication studyAges 19–60United States
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 19 years to 60 years. Other eligibility criteria apply.
- Listed locations
- Jamaica PlainSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateDecember 1994
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 66
- Sponsor
- Harvard Medical School (HMS and HSDM)
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 19 Years to 60 Years
- Official registry ID
- NCT00169039
- Official title
Show the full official title
Clozapine Response and Biogenic Amines in Schizophrenia
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Jamaica Plain
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Harvard Medical School (HMS and HSDM).
Does this study involve medication?
Yes. The study involves medication, including Clozapine and Chlorpromazine.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 19 years to 60 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
